Monday, October 26, 2026 · Daily editionET --:--:--

Withdrawn before it began

ACHIEVE GRX Registry

NCT04513613 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 23 April 2021

What is being tested
Procedure/Surgery: Robotic-PVI
For
Peripheral Arterial Disease; Peripheral Vascular Diseases; Renal Artery Disease; Carotid Artery Diseases
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. The full rules are on the registry page.
Where
Not stated
When
Starts or started Jan 2022, ends Jan 2023. Registered 14 Aug 2020.
Results
None posted yet.

In the researchers' words

This study will evaluate real-world performance of the CorPath GRX System in peripheral vascular interventions.
ClinicalTrials.gov, NCT04513613